CareDx, Inc (CDNA)
USD 15.0
(-0.46%)
USD 15.0
(-0.46%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 484.61 Million USD | -10.75% |
| 2022 | 542.99 Million USD | -4.17% |
| 2021 | 566.62 Million USD | 53.76% |
| 2020 | 368.51 Million USD | 142.86% |
| 2019 | 151.73 Million USD | 16.1% |
| 2018 | 130.69 Million USD | 56.4% |
| 2017 | 83.56 Million USD | 8.91% |
| 2016 | 76.73 Million USD | 37.91% |
| 2015 | 55.63 Million USD | -9.0% |
| 2014 | 61.14 Million USD | 519.27% |
| 2013 | 9.87 Million USD | -0.03% |
| 2012 | 9.87 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 466.77 Million USD | 3.18% |
| 2024 Q3 | 476.98 Million USD | 2.19% |
| 2024 Q1 | 452.4 Million USD | -6.65% |
| 2023 Q1 | 528.21 Million USD | -2.72% |
| 2023 Q3 | 501.18 Million USD | -2.65% |
| 2023 Q2 | 514.82 Million USD | -2.54% |
| 2023 FY | 484.61 Million USD | -10.75% |
| 2023 Q4 | 484.61 Million USD | -3.31% |
| 2022 Q2 | 541.28 Million USD | -0.99% |
| 2022 Q1 | 546.71 Million USD | -3.51% |
| 2022 FY | 542.99 Million USD | -4.17% |
| 2022 Q4 | 542.99 Million USD | -0.28% |
| 2022 Q3 | 544.51 Million USD | 0.6% |
| 2021 Q4 | 566.62 Million USD | 0.61% |
| 2021 Q2 | 557.41 Million USD | 2.99% |
| 2021 Q3 | 563.17 Million USD | 1.03% |
| 2021 FY | 566.62 Million USD | 53.76% |
| 2021 Q1 | 541.22 Million USD | 46.87% |
| 2020 Q2 | 344.74 Million USD | 119.88% |
| 2020 FY | 368.51 Million USD | 142.86% |
| 2020 Q4 | 368.51 Million USD | 4.23% |
| 2020 Q1 | 156.78 Million USD | 3.33% |
| 2020 Q3 | 353.55 Million USD | 2.56% |
| 2019 Q2 | 142.9 Million USD | 11.77% |
| 2019 Q4 | 151.73 Million USD | 4.77% |
| 2019 FY | 151.73 Million USD | 16.1% |
| 2019 Q3 | 144.83 Million USD | 1.35% |
| 2019 Q1 | 127.85 Million USD | -2.17% |
| 2018 Q4 | 130.69 Million USD | 42.92% |
| 2018 Q3 | 91.44 Million USD | 14.48% |
| 2018 Q2 | 79.87 Million USD | 1.17% |
| 2018 Q1 | 78.95 Million USD | -5.52% |
| 2018 FY | 130.69 Million USD | 56.4% |
| 2017 FY | 83.56 Million USD | 8.91% |
| 2017 Q4 | 83.56 Million USD | 11.28% |
| 2017 Q3 | 75.09 Million USD | -3.4% |
| 2017 Q2 | 77.73 Million USD | -3.22% |
| 2017 Q1 | 80.32 Million USD | 4.68% |
| 2016 Q3 | 102.09 Million USD | 1.92% |
| 2016 Q4 | 76.73 Million USD | -24.84% |
| 2016 FY | 76.73 Million USD | 37.91% |
| 2016 Q1 | 48.83 Million USD | -12.23% |
| 2016 Q2 | 100.16 Million USD | 105.11% |
| 2015 Q3 | 59.34 Million USD | -3.3% |
| 2015 Q2 | 61.36 Million USD | -3.02% |
| 2015 FY | 55.63 Million USD | -9.0% |
| 2015 Q1 | 63.27 Million USD | 3.49% |
| 2015 Q4 | 55.63 Million USD | -6.24% |
| 2014 Q4 | 61.14 Million USD | -2.74% |
| 2014 Q3 | 62.86 Million USD | 84.9% |
| 2014 Q2 | 33.99 Million USD | 206.42% |
| 2014 Q1 | 11.09 Million USD | 12.38% |
| 2014 FY | 61.14 Million USD | 519.27% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 9.87 Million USD | -0.03% |
| 2013 Q4 | 9.87 Million USD | 0.0% |
| 2012 FY | 9.87 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -145.493% |
| Biodesix, Inc. | 99.09 Million USD | -389.036% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -5794.447% |
| Castle Biosciences, Inc. | 477.81 Million USD | -1.424% |
| DarioHealth Corp. | 96.38 Million USD | -402.77% |
| Exact Sciences Corporation | 6.47 Billion USD | 92.511% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | 85.134% |
| Illumina, Inc. | 10.11 Billion USD | 95.207% |
| Intelligent Bio Solutions Inc. | 13.77 Million USD | -3417.09% |
| iSpecimen Inc. | 15.81 Million USD | -2963.473% |
| Standard BioTools Inc. | 323.06 Million USD | -50.004% |
| 23andMe Holding Co. | 395.16 Million USD | -22.635% |
| Medpace Holdings, Inc. | 1.65 Billion USD | 70.75% |
| NeoGenomics, Inc. | 1.68 Billion USD | 71.175% |
| Inotiv, Inc. | 856.53 Million USD | 43.421% |
| Psychemedics Corporation | 13.27 Million USD | -3551.959% |
| Prenetics Global Limited | 254.17 Million USD | -90.665% |
| Precipio, Inc. | 18.1 Million USD | -2577.283% |
| RadNet, Inc. | 2.88 Billion USD | 83.212% |
| Sotera Health Company | 3.13 Billion USD | 84.519% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -457.195% |
| Exagen Inc. | 56.94 Million USD | -751.038% |
| Natera, Inc. | 1.45 Billion USD | 66.742% |
| Aspira Women's Health Inc. | 6.26 Million USD | -7638.981% |
| Neogen Corporation | 4.58 Billion USD | 89.428% |
| Myriad Genetics, Inc. | 1.19 Billion USD | 59.572% |
| ICON Public Limited Company | 16.98 Billion USD | 97.148% |
| Bionano Genomics, Inc. | 214.4 Million USD | -126.029% |
| Check-Cap Ltd. | 25.01 Million USD | -1837.143% |
| Twist Bioscience Corporation | 776.4 Million USD | 37.582% |
| Guardant Health, Inc. | 1.78 Billion USD | 72.872% |
| BioNexus Gene Lab Corp. | 11.39 Million USD | -4151.086% |
| Fulgent Genetics, Inc. | 1.27 Billion USD | 61.935% |
| Sera Prognostics, Inc. | 95.44 Million USD | -407.764% |
| OPKO Health, Inc. | 2.01 Billion USD | 75.91% |
| Personalis, Inc. | 225.09 Million USD | -115.29% |
| Applied DNA Sciences, Inc. | 13.65 Million USD | -3449.883% |
| Star Equity Holdings, Inc. | 86.97 Million USD | -457.195% |
| MDxHealth SA | 129.13 Million USD | -275.287% |
| Prenetics Global Limited | 254.17 Million USD | -90.665% |
| ENDRA Life Sciences Inc. | 6.75 Million USD | -7075.074% |
| Mainz Biomed B.V. | 15.4 Million USD | -3045.007% |
| Trinity Biotech plc | 59.43 Million USD | -715.37% |
| Neuronetics, Inc. | 115.83 Million USD | -318.381% |
| bioAffinity Technologies, Inc. | 8.22 Million USD | -5794.447% |